Epileptic seizure prediction is now possible in a wider range of patients than previously thought, thanks to the crowdsourcing of more than 10,000 algorithms worldwide.
Queensland researchers have conducted a world-first trial comparing the merits of robotic-assisted prostatectomy to open prostatectomy.
'Ivy' is a self-improving artificial intelligence system that continuously learns from the embryos it analyses.
What would normally take decades in identifying the effectiveness of a TB drug could now just take a matter of hours.
Aus-Swiss researchers have developed a miniature biosensor that provides insights into how individual cells behave.
Victorian Clinical Genetics Services' new bio-IT platform is reducing the turnaround time of genomic testing from months to days.
Emerson has selected Enterprise System Partners (ESP), a consulting and project engineering company, to collaborate with and assist life sciences manufacturers in implementing the Syncade manufacturing execution system (MES).
IBM's Clinical Trial Management System (CTMS) for Sites is designed to streamline the clinical trials management process and maximise operational efficiencies.
US researchers have built a lab prototype of a flat microscope, called FlatScope, to provide an alternate path for sight and sound to be delivered directly to the brain. The microscope will sit on the surface of the brain, where it will detect optical signals from neurons in the cortex.
Researchers from The Netherlands have developed a glass microchip for ultrafast separation and purification of DNA fragments.
Researchers at CNBP have developed a nanoscale sensor that can help detect cytokines — molecules that play a critical role in cellular response to infection, inflammation, trauma and disease.
If you thought Photoshop was the cutting edge when it came to editing software, you ain't seen nothing yet.
Applications are now open for the 2016–2017 BeHEARD Challenge, which provides technology and financial grants for rare disease research.
Scientex supplies products to scientists who are associated with the pursuit of know-how in all areas of bioscience.
The co-founder and CEO of laboratory automation company LBT Innovations, Lusia Guthrie, has been appointed chair of Clever Culture Systems (CCS) for a two-year period.